XOMA Corp Files 8-K on Financials
Ticker: XOMAP · Form: 8-K · Filed: Mar 8, 2024 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0075, $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
XOMA Corp dropped its 8-K on March 8, 2024, detailing financial results and operations.
AI Summary
On March 8, 2024, XOMA Corporation filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, with the company's principal executive offices located at 2200 Powell Street, Suite 310, Emeryville, CA 94608. XOMA Corporation is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides an update on XOMA Corporation's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that does not announce any new material events or significant changes.
Key Players & Entities
- XOMA Corporation (company) — Registrant
- 2200 Powell Street, Suite 310, Emeryville, CA 94608 (location) — Principal Executive Offices
- March 8, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for XOMA Corporation?
The primary purpose of this 8-K filing is to report on XOMA Corporation's Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 8, 2024.
Where are XOMA Corporation's principal executive offices located?
XOMA Corporation's principal executive offices are located at 2200 Powell Street, Suite 310, Emeryville, CA 94608.
In which state is XOMA Corporation incorporated?
XOMA Corporation is incorporated in Delaware.
What is XOMA Corporation's Standard Industrial Classification (SIC) code and industry?
XOMA Corporation's Standard Industrial Classification (SIC) code is 2834, which corresponds to the Pharmaceutical Preparations industry.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-03-08 07:39:32
Key Financial Figures
- $0.0075 — nge on which registered: Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
Filing Documents
- d786331d8k.htm (8-K) — 27KB
- d786331dex991.htm (EX-99.1) — 111KB
- g786331g0308091449854.jpg (GRAPHIC) — 8KB
- 0001193125-24-062926.txt ( ) — 324KB
- xoma-20240308.xsd (EX-101.SCH) — 4KB
- xoma-20240308_def.xml (EX-101.DEF) — 14KB
- xoma-20240308_lab.xml (EX-101.LAB) — 23KB
- xoma-20240308_pre.xml (EX-101.PRE) — 15KB
- d786331d8k_htm.xml (XML) — 7KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Number Description of Document 99.1 Press release entitled "XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value" dated March 8, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA CORPORATION Date: March 8, 2024 By: /s/ THOMAS BURNS Thomas Burns Senior Vice President, Finance and Chief Financial Officer